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Abstract
FcγRIIB-/-yaa mice develop severe lupus glomerulonephritis due to lack of an inhibitory
immune cell receptor combined with a Y-chromosome linked autoimmune accelerator muta-
tion. In the present study, we have investigated nephritis development and progression in
FcγRIIB-/-yaa mice to find shared features with NZB/NZW F1 lupus prone mice and human
disease. We sacrificed 25 male FcγRIIB-/-yaa mice at various disease stages, and grouped
them according to activity and chronicity indices for lupus nephritis. Glomerular morphology
and localization of electron dense deposits containing IgG were further determined by
immune electron microscopy. Renal DNase I and pro-inflammatory cytokine mRNA levels
were measured by real-time quantitative PCR. DNase I protein levels was assessed by
immunohistochemistry and zymography. Our results demonstrate early development of
electron dense deposits containing IgG in FcγRIIB-/-yaa mice, before detectable levels of
serum anti-dsDNA antibodies. Similar to NZB/NZW F1, electron dense deposits in FcγRII-
B-/-yaa progressed from being confined to the mesangium in the early stage of lupus nephri-
tis to be present also in capillary glomerular basement membranes. In the advanced stage
of lupus nephritis, renal DNase I was lost on both transcriptional and protein levels, which
has previously been shown in NZB/NZW F1 mice and in human disease. Although lupus
nephritis appears on different genetic backgrounds, our findings suggest similar processes
when comparing different murine models and human lupus nephritis.
Introduction
Lupus nephritis is a serious organ manifestation affecting 20–50% of patients with systemic
lupus erythematosus (SLE) [1, 2]. Up to 25% of patients with lupus nephritis develop end stage
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renal disease despite the emergence of new immunomodulatory agents the last decades [3, 4].
The complex and partly unknown pathogenesis of SLE and lupus nephritis is challenging for
development of new and specific treatments. A diversity of genetic variants has been identified
to increase susceptibility to SLE and lupus nephritis, often in an epistatic manner [5]. Ethical
and practical factors limit human studies, and murine models are therefore essential to identify
the pathological impact of various genes. Common disease features in different murine mod-
els, independent of genetic background, often apply to human lupus nephritis, to become
potential therapeutic targets [6].
The lupus-prone murine model FcγRIIB-/-yaa on a C57BL6 (B6)-background was gener-
ated and first described in 2002 by Bolland et al. In these mice, lack of inhibitory FcγRIIB on
immune cells combined with the Y-chromosome linked autoimmune accelerator (yaa) muta-
tion causes an especially severe variant of glomerulonephritis in male mice [7].
FcγRIIB is the only inhibitory member of Fcγ-receptors, which target IgG immune com-
plexes [8, 9]. When normally expressed on professional antigen presenting cells, plasma cells,
and granulocytes, FcγRIIB prevents autoimmunity by two main mechanisms. First, receptor
stimulation on B-cells increases the threshold of B-cell activation, thereby decreasing the
amount of autoantibodies produced. Second, receptor stimulation on professional antigen pre-
senting cells at the site of inflammation suppresses antigen internalization and production of
pro-inflammatory cytokines [10–12]. Decreased expression levels of FcγRIIB are associated
with autoimmunity in humans [13–17] and in several lupus-prone murine models such as
NZB, BXSB, MRL and NOD [18].
The yaa-mutation is an unbalanced translocation of at least 16 genes from the telomeric
end of the X-chromosome onto the Y-chromosome [19, 20]. Among these genes, toll like recep-
tor 7 (TLR7) is considered the most important gene for the yaa autoimmune phenotype [21,
22]. Activation of TLR7 leads to transcription of type I interferons [23] and the pro-inflamma-
tory cytokines IL-6, IL-10 and TNFα through the NF-κB pathway [24–26], promoting inflam-
matory progression in lupus nephritis.
In FcγRIIB-/-yaa, an accelerating autoimmune inflammation is hence caused by increased
exposure of endogenous nucleic antigens to intracellular TLRs, and especially excessive TLR7
signaling. Early development of anti-nuclear autoimmunity, splenomegaly and lethal glomeru-
lonephritis are characteristic features of this model [7, 27–29]. Studies so far have implicated
anti-dsDNA and anti-ribonuclear protein (anti-RNP) as the main anti-nuclear antibodies [27,
28].
In NZB/NZW F1, we have previously found a two-stepped disease development. The mice
developed mesangial IgG-deposits along with anti-dsDNA antibodies in an early stage, and
IgG-deposits in the glomerular basement membrane (GBM) with severe proteinuria in the
end stage disease. The IgG-deposits in mesangium and GBM colocalized with DNA within
electron dense structures (EDS). At the same time as development of end stage lupus nephritis,
we observed downregulation of renal DNase I expression [30]. A similar pattern was also
observed in human lupus nephritis. Glomerular IgG-deposits in EDS colocalized with DNA,
and renal DNase I downregulation was limited to patients with EDS in the GBM [31]. In addi-
tion, renal gene expression profiling has showed downregulation of DNase I in nephritic
NZM2410 and (NZWxBXSB) F1 mice [32].
As DNase I is the major renal endonuclease [33], loss of DNase I is likely to negatively affect
local chromatin clearance. Based on the two-stepped disease model, we have earlier proposed
that loss of renal DNase I lead to accumulation and exposure of chromatin along renal matri-
ces and membranes, where it serves as a target for anti-chromatin antibodies. Binding of chro-
matin fragment-anti-IgG immune complexes to glomerular membranes may promote
progression of mild mesangial lupus nephritis to end stage kidney disease [30].
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Thus, the aim of the present study was to investigate if the two-stepped lupus nephritis
development and loss of DNase I also applied for FcγRIIB-/-yaa mice. A special focus has been
on histopathology, glomerular targets of anti-dsDNA antibodies, and expression levels of cyto-
kines, toll like receptors (TLRs) and DNase I during disease progression. If nephritis in FcγRII-
B-/-yaa resembles other lupus-prone murine models and the human form of the disease, this
may guide us to new causal therapy strategies–irrespective of the genetic background.
Material and methods
Ethics statements
The study was approved by the Regional Animal Research Authority at the University of
Erlangen-Nurnberg, Germany (Regierung von Mittelfranken, 54–2532.2-3/08 and TS-05/5).
Mice
FcγRIIB-/- mice[34] backcrossed for 12 generations to C57BI/6 were obtained from Taconic
Biosciences and crossed with B6.yaa mice (obtained from Jackson Laboratories). 25 male
FcγRIIB-/- yaa mice were sacrificed at various disease stages by CO2 asphyxiation followed by
cervical dislocation. Seven mice were aged 4–9 weeks and the remaining 18 mice were 26
weeks or older. Proteinuria and serum anti-dsDNA antibody titers were checked every month
from 3–5 months of age. 24-hour urine collection was done immediately before the mice were
sacrificed, and urine samples were stored at -80˚. Four of the youngest mice did not have sera
nor urine for evaluation. Isolated renal tissue from all 25 mice was snap frozen, preserved in
8% formalin for morphologic studies, and embedded in OCT for immunofluorescence
analyses.
Determination of proteinuria and serum antibodies
Urinary protein concentration was determined using protein quantification assay from
Macherey-Nagel (M740967, Duren, Germany) according to the manufacturer instruction.
Briefly urine was diluted to 1:10, mixed with Protein Solving Buffer and subsequently incu-
bated for 30 minutes with Quantification Reagent. After incubation, light extinction is mea-
sured photometrically. The protein concentration is determined in reference to a BSA (Bovine
Serum Albumin) calibration curve.
Anti-dsDNA antibodies in serum were detected using standard indirect ELISA. 96-well
plates were coated with calf thymus DNA (Sigma) and incubated overnight. Wells were incu-
bated with serial dilutions of sera in PBS/0.02% Tween for 1 hour, washed and incubated with
anti-IgG antibodies (Sigma anti-mouse IgG A3673) for 1 hour. O-phenylenediamine dihy-
drochloride (Sigma P8787) in phosphate-citric buffer and 30% hydrogen peroxide were used
as substrate, and the reaction was stopped using HCl. Optical density was read at 492 nm
(Multiskan Ascent, Thermo Electron Corporation). Antibody titers were determined as the
dilution giving 40% of maximum binding of a positive reference serum. PBS/0.05% Tween was
used for washing between steps, and incubations were done at 37˚C.
Anti-RNP antibodies in serum were detected using an ELISA kit according to the instruc-
tion manual (Alpha Diagnostic Intl. 5410).
Immune electron microscopy (IEM) and colocalization IEM
For immune electron microscopy, renal samples were fixated in 8% formaldehyde in PBS and
cortex samples were further processed in sucrose and glycine as described [35]. Ultrathin cryo-
sections were incubated with goat anti-mouse IgG conjugated with 6-nm gold particles
Nephritis development in FcγRIIB-/-yaa mice
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(Jackson ImmunoResearch Laboratories, Inc.) to correlate the morphological changes with the
presence of antibodies bound in the glomeruli in vivo as described in [36]. The grids were con-
trasted with uranyl acetate and examined at x10-x40 K magnification using a JEM-1010 trans-
mission electron microscope (Jeol, Tokyo, Japan). One glomerulus from each mouse was
evaluated. Two mice were not evaluated because of insufficient quality of the sections. Pres-
ence of 1) mesangial EDS and 2) EDS in the capillary GBM were scored in a semi-quantitative
way: 0, negative; 1+, 1–3 EDS locations; 2+, >3 EDS locations. In addition, podocyte foot pro-
cess effacement was scored semi-quantitatively: 0, negative; 1+, average width of podocyte foot
processes >1 μm; 2+, absence of podocyte foot processes.
To determine whether in vivo-bound autoantibodies were colocalized with extracellular
chromatin, ultrathin cryosections were processed as described above. Sections were incubated
with rabbit anti-mouse IgG (Cappel, ICN Pharmaceuticals, Inc.) and protein A conjugated
with 5-nm gold particles (PAG-5nm, University of Urecht, The Netherlands), in addition to
anti-dsDNA mAb DNA6 and protein A conjugated with 10-nm gold particles (PAG-10nm).
Micrographs were taken using JEM-1010 transmission electron microscope (Jeol, Tokyo,
Japan). The method is described in details in [36].
Histology and immunohistochemistry (IHC)
Paraffin-embedded formalin fixated renal tissue were cut in 4 μm sections. For morphologic
evaluation, sections with hematoxylin and eosin stain and periodic acid-schiff (PAS) stain
were scored blinded by a pathologist for determination of activity index (0–24) and chronicity
index (0–12), as formulated by Austin et al [37].
Protein expression of DNase I and TLR7 in renal sections were evaluated by immunohis-
tochemistry. After deparaffinization and rehydration of 4 μm renal paraffin-embedded sec-
tions, sections were heated up to 97˚C for 20 minutes in a citrate buffer pH 6.0. The sections
were then blocked for 8 minutes with Peroxidase Block supplied by the kit, and 30 minutes for
nonspecific hydrophobic binding with 10% goat serum (Invitrogen) in PBS. The sections were
incubated with the primary antibody for 30 minutes (LifeSpan DNase I LS-B4846, Abcam
TLR7 ab45371). Secondary antibody and chromogen-solution were applied according to the
manufacturers manual (Dako EnVision+ HRP Rabbit (DAB+) kit, K4011). Counterstaining
was then preformed using hematoxylin and Scotts solution.
Direct immunofluorescence (IF) microscopy
IgG deposits in renal tissue were detected on OCT-embedded 4 μm cryosections. The sections
were fixated in Hepes-buffered paraformaldehyde, and then blocked in 5% goat serum (Invi-
trogen) for 20 minutes. Next, the sections were incubated with F(ab’)-goat anti-mouse IgG (H
+L) (Invitrogen, A-11018) and counterstained with DAPI (Abbot, 06J49-001).
RNA isolation and cDNA synthesis
Total RNA from snap frozen kidneys was isolated by Quiagen miRNeasy Mini Kit (217004)
according to their protocol. The RNA concentration was measured spectrophotometrically
with NanoDrop (NanoDrop technologies). Samples were reverse transcribed using High
Capacity cDNA Reverse Transcription Kit (ThermoFisher Scientific).
Real-time quantitative PCR analysis
Real-time quantitative PCR was preformed using predesigned TaqMan Gene Expression
Assays (ThermoFisher Scientific). TATA-box Bindi006Eg Protein (TBP) and β-actin were
Nephritis development in FcγRIIB-/-yaa mice
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used as housekeeping gene controls. The following accession numbers for individual primers
and probes were: IL-1β Mm9999061_m1, IL-6 Mm00446190_m1, IL-10 Mm9999062_m1,
TNFα Mm00443258, IFNγ Mm01168134, TLR7 Mm00446590_m1, TLR8 Mm01157262_m1,
TLR9 Mm00446193_m1, Eif2ak2 Mm01235643_m1, Ifit1 Mm00515153_m1, Mx1
Mm00487796_m1, DNase1 Mm01342389_g1, TBP Mm00446973_m1 and β-actin 4352933E.
Relative expression levels of mRNA were calculated using the ΔΔCT method.
Renal protein isolation
Protein isolation was done by homogenizing a cross-section of snap frozen renal tissue in
DNase I Reaction Buffer with 0.1% Triton and 0.1% Protease Inhibitor Cocktail (P8340
Sigma), using Precellys24 (Bertin Instruments) 6000 rpm 2 x 15 seconds. Samples were centri-
fuged at 13.000 G for 5 min at 4˚C. Protein concentration was measured using DirectDetect
Infrared Spectrometer (Merk Millipore). Samples were normalized to protein concentration of
1.0 mg/ml, and used for single radial enzyme diffusion (SRED) and zymography analysis.
Single radial enzyme diffusion (SRED)
DNase I activity was quantified using SRED. 1% agarose gel made on DNase I reaction buffer
(40mM Tris, ph 7.6 / 2mM CaCl2 / 2mM MgCl2) was heated up until the solution was fully dis-
solved, and cooled down to 60˚C before adding 300 μl salmon sperm DNA (Invitrogen) and
20 μl GelRed (Biotium, 41003) to a 100 ml solution. After the gel solidified, 3.5 μl of sample
were loaded into wells of 1.0 mm diameter. An UV-picture was captured after 22 hours incu-
bation at 37˚C in a humid chamber, and the circle perimeter reflecting DNase I activity was
measured. Recombinant human DNase I (DNASE15-R-100, Alpha Diagnostic Intl. Inc.) was
used in four concentrations (0.1 IU, 0.025 IU, 0.0063 IU and 0.0016 IU) to make the standard
curve for each gel.
DNase I zymography
DNase I activity in the kidneys was detected by DNase I zymography, as described [38, 39].
Briefly, proteins were separated in 10% SDS-polyacrylamide gels containing 100 ng⁄ml heat-
denatured salmon sperm DNA (Invitrogen Corp.). SDS was removed after electrophoresis by
washing the gel in 2% Triton X-100 in miliQ water for 1 hour at room temperature. The gel
was incubated in DNase I reaction buffer at 37˚C for 18 hours and stained with GelRed for 30
minutes. UV-picture was captured to show dark areas were active DNase I had digested DNA
in the gel. Recombinant human DNase I (DNASE15-R-100, Alpha Diagnostic Intl. Inc.) was
used as a control.
Statistics
Values in histograms are presented as mean with standard deviation. Differences between
groups were analyzed with one-way ANOVA using a Games-Howell post hoc test. Spearman’s
rank-order correlation coefficient (rs) was used for bivariate correlation analysis, with a two-
tailed statistical significance. IBM SPSS statistics 24 software was used for statistical analysis. P-
values<0.05 were considered significant.
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Results
FcγRIIB-/-yaa mice develop glomerular EDS containing IgG in early
disease stages, before positive anti-dsDNA titers and considerable
proteinuria
General disease features of lupus nephritis in FcγRIIB-/-yaa mice were evaluated by renal
microscopy (Fig 1, Fig 2A), presence of serum anti-dsDNA and anti-RNP antibodies (Fig 2B
and 2C), proteinuria (Fig 2D) and renal expression levels of pro-inflammatory cytokines (Fig
2E). Mice were grouped according to activity and chronicity indices for lupus nephritis: mini-
mal nephritis (activity index2, chronicity index 0), moderate nephritis (activity index >2,
chronicity index 0) and severe nephritis (chronicity index1) (S1 Table). Mice with severe
nephritis also had the highest activity index (Fig 2A).
In the minimal nephritis group, seven of nine animals were 4–9 weeks old (Table 1), and
had changes in renal morphology such as glomerular endocapillary proliferation, glomerular
neutrophil infiltration and/or presence of mononuclear cells in the interstitium (Fig 1, PAS
staining; S1 Table). 66% of mice with minimal nephritis had various degrees of mesangial EDS
containing IgG, and 22% had additional EDS containing IgG in the capillary GBM (Table 1).
Immunofluorescence showed some but weak IgG staining in glomeruli (Fig 1). All mice in this
group had normal morphology of podocyte foot processes, and no or negligible proteinuria
(Table 1; Fig 2D). Most of them were negative for anti-dsDNA antibodies, and the only mouse
with a very low positive titer was older than 26 weeks (Fig 2B; Table 1; S1 Fig). However, all
mice with minimal nephritis had detectable levels of anti-RNP antibodies (Fig 2C).
11 mice were included in the moderate nephritis group, and were all 26 weeks or older
(Table 1). Characteristic histopathologic features of these mice were endocapillary prolifera-
tion and enlargement of glomeruli, infiltration of inflammatory cells in glomeruli and intersti-
tium, and formation of wire loops and hyaline thrombi. Some mice also developed cellular
crescents and glomerular fibrinoid necrosis (Fig 1, PAS staining; S1 Table). IEM revealed mas-
sive mesangial EDS containing IgG in all mice with moderate nephritis, while 80% had some
degree of EDS containing IgG localized in the subendothelial and/or the subepithelial area of
capillary GBM (Table 1). IgG deposits in mesangium and along capillary walls were also dem-
onstrated by immunofluorescence (Fig 1). Podocyte effacement was apparent in 60% of ani-
mals. Most mice had a positive anti-dsDNA titer and proteinuria (Fig 2B and 2D; Table 1; S1
Fig). Serum anti-RNP antibodies were detected in all mice with moderate nephritis. However,
anti-RNP activity concentrations were similar to those detected in mice with minimal nephri-
tis (Fig 2C).
Five mice had severe nephritis, all 26 weeks or older (Table 1). In addition to pathologic
changes associated with active nephritis, these mice also presented initial chronic changes with
fibrous crescents and tubular atrophy (Fig 1, PAS staining; S1 Table). All mice had EDS con-
taining IgG in the mesangium and in the capillary GBM, and podocyte effacement by IEM
(Table 1). As for the moderate nephritis group, anti-IgG immunofluorescence reflected the
heavy burden of IgG-deposits seen by IEM (Fig 1). All mice had positive anti-dsDNA titers
and proteinuria (Fig 2B and 2D; Table 1, S1 Fig). Serum anti-RNP activity concentrations
remained the same as detected in mice with minimal and moderate nephritis (Fig 2C).
Renal proinflammatory cytokines are elevated in moderate and severe
disease in FcγRIIB-/-yaa mice
Renal mRNA expression levels of IL-1β, IL-6, IL-10, TNFα and IFNγ were analyzed to evaluate
how the local inflammatory milieu correlated to morphologic changes. Relative expression
Nephritis development in FcγRIIB-/-yaa mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0188863 November 30, 2017 6 / 18
levels in mice with moderate and severe nephritis were calculated using the average expression
level of minimal nephritis group as a reference. As demonstrated in Fig 2E, the renal proin-
flammatory cytokines were in general elevated in moderate and severe nephritis, whereas IL-
10 was significantly upregulated in severe nephritis.
Fig 1. Renal morphology in different disease stages. Typical micrographs from minimal, moderate, and severe nephritis. Periodic
acid-Schiff (PAS) staining in the left panel show increasing changes in glomeruli and tubulointerstitium with disease progression:
endocapillary proliferation, infiltration of immune cells, formation of wire loops and hyaline thrombi, crescents, atrophy and sclerosis. The
middle panel demonstrate immune electron microscopy (IEM) with anti-IgG antibodies (6 nm gold) showing increasing amounts of IgG-
deposits (arrows) in mesangium and later also in the capillary glomerular basement membrane. In addition, podocyte effacement was
apparent in moderate and severe nephritis. Immunofluorescence (IF) in the right panel shows IgG staining in glomeruli for all three groups,
and also staining in the tubulointerstitium in mice with moderate and severe nephritis.
https://doi.org/10.1371/journal.pone.0188863.g001
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Colocalization IEM revealed in vivo bound IgG and DNA in glomerular
EDS in FcγRIIB-/-yaa mice
Renal sections with minimal nephritis and severe nephritis were analyzed by colocalization
IEM to characterize the glomerular targets of anti-ds DNA antibodies. As demonstrated in Fig
3, IgG-bound 5 nm gold particles colocalized with DNA-bound 10 nm gold particles almost
exclusively within EDS. IgG and DNA colocalization was confirmed in EDS of both minimal
nephritis and severe nephritis. The density of both 5 nm and 10 nm gold particles was much
higher in the late stage of the disease.
In FcγRIIB-/-yaa mice, the activity index has highly significant
correlations with IEM-evaluated glomerular disease features, proteinuria
and anti-dsDNA antibody titer
We used correlation analysis to identify the strongest factors having impact on lupus nephritis
progression in FcγRIIB-/-yaa. As shown in Table 2, we used Spearman’s correlation on
Fig 2. General disease features of lupus nephritis. Mice with minimal nephritis (Min, n = 9), moderate nephritis
(Mod, n = 11) and severe nephritis (Sev, n = 5) were compared according to different disease parameters. 20/25
mice had end-stage sera and urine available for ELISA and proteinuria evaluation: Min n = 5, Mod n = 10, Sev n = 5.
(A) Distribution of activity and chronicity indices of renal tissue in the different groups, presented as mean with
standard deviations. Mean activity index was highest in the severe nephritis group, which also had chronic changes.
(B) Mean anti-dsDNA antibody titer with standard deviations. Mice with severe nephritis had elevated anti-dsDNA
antibody titer compared to minimal nephritis (p = 0.023). (C) Mean anti-RNP activity concentrations (U/ml) with
standard deviations. (D) Urinary protein concentrations (μg/μl) with standard deviations. (E) Renal cytokine mRNA
levels, presented as fold change relative to the mice with minimal nephritis. IL-10 was significantly upregulated in
mice with severe nephritis compared to minimal nephritis (p = 0.041).
https://doi.org/10.1371/journal.pone.0188863.g002
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multiple variables such as age, renal morphological changes, proteinuria, and presence of anti-
dsDNA antibodies. The activity index correlated significantly with age (p = 0.002), mesangial
EDS containing IgG (p = 0.001), EDS containing IgG in capillary GBM (p = 0.001), podocyte
effacement (p<0.001), proteinuria (p = 0.037), and anti-dsDNA antibody titer (p = 0.002).
Proteinuria and anti-dsDNA antibodies also showed significant correlations with most param-
eters. Age on the other hand correlated only significantly with the amount of mesangial EDS
(p<0,001).
Table 1. Distribution of various lupus nephritis parameters within different disease stages.








Minimal nephritis 9 weeks: 7 (78%) Score 0: 3 (33%) Score 0: 7 (78%) Score 0: 9 (100%) Neg: 4 (80%) <0.5: 3 (60%)
Score 1: 3 (33%) Score 1: 2 (22%) Score 1: - Pos: 1 (20%) 0.5–5: 2 (40%)
26 weeks: 2 (22%) Score 2: 3 (33%) Score 2: - Score 2: - >5: -
Moderate nephritis 9 weeks: - Score 0: - Score 0: 2 (20%) Score 0: 4 (40%) Neg: 4 (40%) <0.5: -
26 weeks: 11 (100%) Score 1: - Score 1: 6 (60%) Score 1: 5 (50%) Pos: 6 (60%) 0.5–5: 8 (80%)
Score 2: 10 (100%) Score 2: 2 (20%) Score 2: 1 (10%) >5: 2 (20%)
Severe nephritis 9 weeks: - Score 0: - Score 0: - Score 0: - Neg: - <0.5: -
26 weeks: 5 (100%) Score 1: - Score 1: 1 (25%) Score 1: - Pos: 5 (100%) 0.5–5: 2 (40%)
Score 2: 4 (100%) Score 2: 3 (75%) Score 2: 4 (100%) >5: 3 (60%)
Mice were divided into groups according to renal histological changes scored by activity and chronicity indices for lupus nephritis: minimal nephritis, n = 9;
moderate nephritis, n = 11; and severe nephritis, n = 5. The different lupus nephritis parameters were: age, the degree of electron dense structures (EDS) in
mesangium (score 0–2), the degree of EDS in the glomerular basement membrane (GBM) lining capillary lumen (score 0–2), the degree of podocyte foot
process (PFP) effacement (0: normal morphology, 1: fusion of PFP, 2: loss of PFP), the presence of anti-dsDNA antibodies, and the level of proteinuria.
*23/25 mice had sufficient quality of sections for IEM evaluation.
a20/25 mice had end-point sera available for anti-dsDNA ELISA.
b20/25 mice had end-point urine available for proteinuria evaluation.
https://doi.org/10.1371/journal.pone.0188863.t001
Fig 3. IgG and DNA colocalization immune electron microscopy. Renal sections from mice with minimal
nephritis (upper panel) and severe nephritis (lower panel) were incubated with anti-IgG (5 nm gold) and anti-
DNA (10 nm gold). IgG were restricted to EDS, and colocalized with DNA. Both IgG and DNA appeared with
highest density in severe nephritis.
https://doi.org/10.1371/journal.pone.0188863.g003
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TLR7 is expressed in tubular epithelial cells in FcγRIIB-/-yaa mice
Since TLR7 is duplicated as a result of the yaa-mutation, we used IHC analysis to study the
renal protein expression in different disease stages. Surprisingly, we found TLR7 staining in
tubular epithelial cells in all groups of FcγRIIB-/-yaa mice, in addition to the expected staining















Age rs* 1 0.591 0.708 0.411 0.329 0.136 0.431 -0.062 0.608
p
valuea
0.002 0.000 0.051 0.125 0.566 0.058 0.770 0.001
nb 25 25 23 23 23 20 20 25 25
Activity index rs* 0.591 1 0.653 0.639 0.808 0.469 0.643 -0.585 0.798
p
valuea
0.002 0.001 0.001 0.000 0.037 0.002 0.002 0.000
nb 25 25 23 23 23 20 20 25 25
EDS
mesangium
rs* 0.708 0.653 1 0.540 0.495 0.491 0.357 -0.086 0.624
p
valuea
0.000 0.001 0.008 0.016 0.039 0.146 0.696 0.001
nb 23 23 23 23 23 18 18 23 23
EDS capillary
GBM
rs* 0.411 0.639 0.540 1 0.599 0.453 0.580 -0.490 0.595
p
valuea
0.051 0.001 0.008 0.003 0.059 0.012 0.018 0.003
nb 23 23 23 23 23 18 18 23 23
Podocyte
effacement
rs* 0.329 0.808 0.495 0.599 1 0.609 0.438 -0.547 0.605
p
valuea
0.125 0.000 0.016 0.003 0.007 0.069 0.007 0.002
nb 23 23 23 23 23 18 18 23 23
Proteinuria rs* 0.136 0.469 0.491 0.453 0.609 1 0.503 -0.263 0459
p
valuea
0.566 0.037 0.039 0.059 0.007 0.028 0.262 0.042
nb 20 20 18 18 18 20 19 20 20
Anti-dsDNA
titer
rs* 0.431 0.643 0.357 0.580 0.438 0.503 1 -0.566 0.671
p
valuea
0.058 0.002 0.146 0.012 0.069 0.028 0.009 0.001
nb 20 20 18 18 18 19 20 20 20
DNase I mRNA rs* -0.062 -0.585 -0.086 -0.490 -0.547 -0.263 -0.566 1 -0.468
p
valuea
0.770 0.002 0.696 0.018 0.007 0.262 0.009 0.018
nb 25 25 23 23 23 20 20 25 25
TLR7 mRNA rs* 0.608 0.798 0.624 0.595 0.605 0459 0.671 -0.468 1
p
valuea
0.001 0.000 0.001 0.003 0.002 0.042 0.001 0.018
nb 25 25 23 23 23 20 20 25 25
The relationship between age, activity index for lupus nephritis, amount of mesangial electron dense structures (EDS), amount of EDS in the glomerular
basement membrane (GBM) lining capillary lumen, degree of podocyte effacement, proteinuria, anti-dsDNA antibody titer, and renal mRNA expression
levels of DNase I and TLR7 were scored.
*Spearman’s correlation coefficient.
aTwo-tailed statistical significance.
bNumber of mice included in the correlation analysis.
https://doi.org/10.1371/journal.pone.0188863.t002
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of immune cells (Fig 4A). The staining pattern of tubular epithelial cells resembled the peri-
nuclear staining pattern of immune cells in lymphoid aggregates in the kidneys (Fig 4A).
Renal levels of TLRs and interferon stimulated genes are upregulated in
moderate and severe lupus nephritis in FcγRIIB-/-yaa mice
We analyzed renal mRNA expression levels of TLR7, TLR8 and TLR9 in different disease
stages to evaluate the potential of receptor activation and downstream transcription of type I
interferons. As seen in Fig 3B, TLR7 was significantly upregulated in mice with moderate and
severe nephritis, and TLR9 was significantly upregulated in moderate nephritis (Fig 3B).
mRNA expression of TLR7 correlated well with mRNA expression of TLR8 (rs: 0.973,
p<0.001) and TLR9 (rs: 0.812, p<0.001), as well as all disease parameters presented in Table 2.
To detect local interferon signaling, we investigated renal expression of the interferon-stim-
ulated genes Eif2ak2, Ifit and Mx1 (Fig 4C). Mx1 was significantly upregulated in moderate
nephritis.
Fig 4. Renal expression of TLRs and interferon stimulated genes. Different disease stages were compared: Minimal nephritis (Min,
n = 9), moderate nephritis (Mod, n = 11), and severe nephritis (Sev, n = 5). (A) IHC demonstrated renal TLR7 expression in tubular
epithelial cells in mice with different stages of FcγRIIB-/-yaa nephritis. The perinuclear staining pattern of tubular epithelial cells resembled
the staining pattern of infiltrating immune cells, as demonstrated for moderate nephritis (enlarged section). (B) Renal mRNA levels of TLR7,
TLR8 and TLR9 from FcγRIIB-/-yaa mice with different stages of nephritis, presented as fold change relative to the minimal nephritis group.
Expression levels of TLR7 and TLR9 were significantly upregulated in mice with moderate nephritis compared to mice with minimal
nephritis (p = 0.006 and p = 0.027, respectively). In mice with severe nephritis, TLR7 was significantly upregulated compared to minimal
nephritis (p = 0.017). (C) Renal mRNA expression levels of the interferon stimulated genes Eif2ak2, Ifit1 and Mx1 in FcγRIIB-/-yaa mice with
different stages of nephritis, presented as fold change relative to the minimal nephritis group. Mx1 was significantly upregulated in
moderate nephritis compared to mice with minimal nephritis (p = 0.008).
https://doi.org/10.1371/journal.pone.0188863.g004
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Renal DNase I is downregulated in severe lupus nephritis in
FcγRIIB-/-yaa
In order to verify whether progression of lupus nephritis in FcγRIIB-/-yaa mice was associated
with loss of DNase I, we analyzed mRNA, protein levels and enzyme activity of renal DNase I
in different disease stages. As demonstrated in Fig 5A, mRNA levels of DNase I were markedly
reduced in kidneys with severe nephritis, while mice with moderate disease had similar
mRNA expression levels to mice with minimal nephritis. The low DNase I mRNA levels in
severe nephritis were also reflected by low renal protein expression, as demonstrated by IHC
analysis (Fig 5B), and renal enzyme activity as demonstrated by single radial enzyme diffusion
assay (Fig 5C) and DNase I gel zymography (Fig 5D).
Thus, late stage of lupus nephritis in FcγRIIB-/-yaa mice is characterized by loss of renal
DNase I on the gene expression, protein expression and enzyme activity levels. As demon-
strated in Table 2, there is a significant negative correlation between DNase I mRNA levels
and activity index (p = 0.002), the amount of EDS containing IgG in capillary GBM
(p = 0.018), podocyte effacement (p = 0.007), and anti-dsDNA antibody titer (p = 0.009).
Fig 5. Renal DNase I expression. Different disease stages were compared: minimal nephritis (Min, n = 9), moderate nephritis (Mod,
n = 11), and severe nephritis (Sev, n = 5). DNase I expression was downregulated in mice with severe nephritis on transcriptional, protein
end enzyme activity levels. (A) Fold change of renal DNase I mRNA levels in mice with moderate and severe lupus nephritis relative to the
minimal nephritis group, showing a highly significant downregulation in mice with severe nephritis compared to minimal nephritis and
moderate nephritis (p<0.001 and p = 0.002, respectively). (B) Immunohistochemistry demonstrated tubular staining of DNase I in mice
with minimal nephritis and moderate nephritis, and weak staining in mice with severe nephritis. (C) Renal DNase I enzyme activity
measured by single radial enzyme diffusion. The enzyme activity was significantly lower in mice with severe nephritis compared to the
minimal nephritis and moderate nephritis (p = 0.001 and p<0.001, respectively). (D) DNase I gel zymography showing enzyme activity of
two typical samples from each group of mice. The enzyme activity was lower in mice with severe nephritis compared to the minimal and
moderate nephritis group. Recombinant DNase I was used as a control (left band).
https://doi.org/10.1371/journal.pone.0188863.g005
Nephritis development in FcγRIIB-/-yaa mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0188863 November 30, 2017 12 / 18
Discussion
FcγRIIB-/-yaa mice developed glomerular EDS containing IgG before early diagnostic signs
such as measurable titers of anti-dsDNA antibodies and proteinuria. Young animals (4–9
weeks) presented primarily mesangial EDS, while older mice with increasing signs of active
nephritis also developed EDS in the capillary GBM. The capillary GBM deposits appeared at
the same time as positive anti-dsDNA titers, but before heavy proteinuria and loss of renal
DNase I. In addition, TLR7 was expressed by tubular epithelial cells, and was highly upregu-
lated in moderate and severe disease.
In contrast to human disease, there is no consensus on classification of murine lupus
nephritis. Assuming a homogenous disease progression, age is commonly used as a classifica-
tion criterion in lupus-prone murine models. However, in the present study and in our previ-
ous longitudinal study of NZB/NZW F1 mice [30], we found considerable age-variation in
disease development. Similar to human classification, presence and localization of EDS were
used to group NZB/NZW F1 mice, but was less suitable for FcγRIIB-/-yaa mice in this study
because of early EDS development. Here, we adapted activity and chronicity indices used for
human lupus nephritis to our murine study. As pointed out in our correlation analysis, renal
activity score for lupus nephritis correlated well with common disease parameters such as glo-
merular EDS, proteinuria and anti-dsDNA antibodies. Activity and chronicity indices were
therefore used as classification criteria for different disease stages in FcγRIIB-/-yaa mice.
In FcγRIIB-/-yaa, the negative anti-dsDNA antibody titer in the minimal nephritis group
may indicate that immune complexes in EDS contain other antigens than DNA. We detected
anti-RNP antibodies in all mice, including mice with minimal nephritis. Also previous studies
on FcγRIIB-/-yaa have found elevated levels of anti-RNP antibodies in an earlier stage com-
pared to anti-dsDNA and anti-chromatin antibodies [27, 28]. Similar to the NZB/NZW F1
study, we here demonstrate colocalization of IgG and DNA in early mesangial deposits as well
as in later deposits in GBM by IEM, indicating that low serum levels of anti-dsDNA antibodies
may be nephritogenic in very early disease. As serum levels of antibodies only reflect the
amount of the unbound fraction, fully absorbed anti-dsDNA antibodies to chromatin in the
kidney would result in negative to low serum titers.
As lupus nephritis progressed in FcγRIIB-/-yaa mice, mesangial EDS containing IgG were
increasingly prominent, and appeared before additional EDS containing IgG in the capillary
GBM. EDS in subendothelial and subepithelial areas of GBM appeared in moderate nephritis
associated with positive anti-dsDNA titers and proteinuria. Lupus nephritis progression
through a mesangial stage before GBM deposits is also thoroughly reported for NZB/NZW F1
mice [30]. In human lupus nephritis, two recent studies following class II patients described
progression to class III or IV despite treatment [40, 41], although class II mesangial nephritis
traditionally is considered benign without progression [42].
Loss of DNase I was apparent in severe lupus nephritis in FcγRIIB-/-yaa mice. Although
loss of DNase I in late stage disease is well known in other models, the cause and impact of
DNase I silencing is still unclear. The role of DNase I in lupus nephritis development has been
discussed for the last 40 years. The idea of chromatin-containing immune complexes due to
reduced serum DNase I levels suggested DNase I as a promising substitutive therapy [43].
However, intravenous and subcutaneous administration of recombinant DNase I in lupus
nephritis patients and NZB/NZW F1 mice did not show any impact on kidney function or dis-
ease activity [44, 45]. These results may indicate that serum DNase I is not important in the
degradation of dying renal cells, and that renal DNase I levels could be important for local
chromatin degradation.
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DNase I is mainly expressed in tubular epithelial cells, where it represent 80% of all endonu-
clease activity [33, 46]. However, DNase I is also found in glomeruli [31]. In NZB/NZW F1
mice, loss of renal DNase I occurred simultaneously with appearance of DNA-IgG complexes
in GBM and severe proteinuria [30]. In FcγRIIB-/-yaa mice, capillary EDS in glomeruli
appeared in early disease stages, before heavy proteinuria and loss of DNase I. Thus, in this
study, loss of DNase I cannot explain the widespread glomerular IgG deposits in moderate
nephritis. Recently, it was shown that anti-dsDNA antibodies bind to tubular epithelial cells,
contributing to tubulointerstitial inflammation [47]. Tubular DNase I levels may therefore
affect the amount of chromatin-containing immune complexes and the overall renal inflam-
mation. Interestingly, FcγRIIB-/-yaa mice with initial chronic inflammatory changes in the kid-
ney showed reduced DNase I expression. Chronic inflammatory signaling pathways may play
an important role in promoting downregulation of DNase I.
TLR7 was highly upregulated in renal tissue during disease progression. TLR7 is normally
only expressed in plasmacytoid dendritic cells, macrophages and B cells [48, 49]. In this study
we also found TLR7 expressed by tubular epithelial cells in FcγRIIB-/-yaa, a possible outcome
of the TLR7 gene duplication. Upregulation of TLR7 expression in nephritic mice, as well as
highly significant correlation with TLR9 expression levels, indicate that the disease process
itself also contributes to TLR7 expression.
Tubular epithelial cells are well known for their capability to become activated by interferon
gamma to express MHC class II and co-stimulatory molecule B7, and thereby function as anti-
gen-presenting cells with the capacity to prime T cells [50, 51]. A recent study on human lupus
nephritis found renal tubular epithelial cells to be the main producers of IFNα, at the same time
as IFNα induced expression of TLR3 in the same cells [52]. Thus, expression of TLR7 in tubular
cells, in addition to professional antigen presenting cells, may contribute to local interferon lev-
els and transcription of other proinflammatory cytokines, driving lupus nephritis progression.
Conclusions
FcγRIIB-/-yaa mice develop early morphologic changes characteristic of lupus nephritis. Before
detectable levels of serum anti-dsDNA antibodies, we observed glomerular proliferation,
immune cell infiltration, and development of glomerular EDS containing IgG in kidneys of
FcγRIIB-/-yaa mice. These findings might reflect the excessive TLR7 signaling and subsequent
upregulation of type I interferons and pro-inflammatory cytokines, causing a stronger autoim-
mune tendency in FcγRIIB-/-yaa compared to other lupus-prone murine models.
Despite of differences in genetic background causing autoimmunity, lupus nephritis pro-
gression in FcγRIIB-/-yaa mice shares characteristics with human disease and other lupus-
prone murine models. Glomerular EDS progress from being confined to the mesangium in
the early stage of lupus nephritis to be present also in GBM. In severe lupus nephritis, DNase I
is lost on both transcriptional and protein levels. This study suggests chronic inflammatory
pathways to cause DNase I downregulation, which may also apply to human disease and other
lupus prone models.
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S1 Fig. Anti-dsDNA antibody titers in individual mice. 6/25 mice had sera available for anti-
dsDNA ELISA at several time points in addition to end stage sera.
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